Your browser doesn't support javascript.
loading
Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study.
Oulhaj, Abderrahim; Alsuwaidi, Ahmed R; Suliman, Abubaker; Gasmelseed, Huda; Khan, Shaima; Alawi, Shamma; Hukan, Yaman; George, Junu; Alshamsi, Fayez; Sheikh, Farrukh; Babiker, Zahir Osman Eltahir; Prattes, Juergen; Sourij, Harald.
Afiliação
  • Oulhaj A; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; Zayed Center for Health Sciences, United Arab Emirates University, United Arab Emirates. Electronic address: aoulhaj@uaeu.ac.ae.
  • Alsuwaidi AR; Department of Paediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Suliman A; Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Gasmelseed H; Al Ain Hospital, Al Ain, United Arab Emirates.
  • Khan S; Academic Affairs Department, Tawam Hospital, Al Ain, United Arab Emirates.
  • Alawi S; Academic Affairs Department, Tawam Hospital, Al Ain, United Arab Emirates.
  • Hukan Y; Academic Affairs Department, Tawam Hospital, Al Ain, United Arab Emirates.
  • George J; Department of Paediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Alshamsi F; Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
  • Sheikh F; Al Ain Hospital, Al Ain, United Arab Emirates.
  • Babiker ZOE; Division of Infectious Diseases, Sheikh Shakhbout Medical City in Partnership with Mayo Clinic, Abu Dhabi, United Arab Emirates.
  • Prattes J; Department of Internal Medicine, Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Austria.
  • Sourij H; Zayed Center for Health Sciences, United Arab Emirates University, United Arab Emirates; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Austria.
Int J Infect Dis ; 107: 188-194, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33862208

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Ativador de Plasminogênio Tipo Uroquinase / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Ativador de Plasminogênio Tipo Uroquinase / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article